| Name | Title | Contact Details |
|---|
Founded nearly 50 years ago and employing over 2,500 clinical, regulatory, and operational pharmacy professionals, Comprehensive Pharmacy Services is the nation`s oldest and largest provider of pharmacy support services to more than 700 hospitals and healthcare facilities across the United States and Puerto Rico. CPS helps hospital pharmacists tackle complex problems such as medication reconciliation, hyper-inflated drug costs, standardization, centralized distribution, regulatory & compliance, and 340B programs leading to increased quality, reduced admissions and lower costs. Services provided by CPS include pharmacy management, pharmacy consulting, specialized pharmacy services, telepharmacy, 340B program compliance assurance, ambulatory & retail pharmacy services, medication related transition of care, and pharmacy analytics.
Daktari Diagnostics is a healthcare solutions company that enables enhanced disease management in both developed and developing countries. Our portable point-of-care diagnostic platform, with built-in wireless connectivity and an intuitive cloud-based data management system, provides the real-time information necessary to improve clinical outcomes for individual patients and support global disease elimination programs. Daktari`s initial products will target viruses of worldwide significance, including Hepatitis C and HIV. The company recently announced a Hepatitis C partnership with Merck & Co (MSD).
Endo Optiks Inc is a Little Silver, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Morris and Associates is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
T3D Therapeutics` mission is to develop its lead drug product candidate, T3D-959, as a potential `First-in-Class`and `Best-in-Class` disease-modifying, breakthrough medicine for the treatment of Alzheimer`s disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D=959 and has initiated pre-clinical studies in Huntington’s Disease models.